Port Access Cardiac Operations Can Be Safely Performed With Either Endoaortic Balloon or Chitwood Clamp

摘要

Study DesignOperative ApproachStatistical AnalysisResultsAnalysis of Preoperative Patient VariablesQuantification of Operative VariablesAnalysis of Postoperative Clinical OutcomesCommentLimitationsDiscussionReferencesMinimally invasive, right thoracotomy (port access) approaches to intracardiac operations (mitral valve, tricuspid valve, atrial septal defect, intracardiac tumors) are becoming increasingly accepted by surgeons, cardiologists, and patients alike. Standard techniques for?cardioplegic arrest of the heart have included endoaortic balloons and Chitwood clamps. Concerns have been raised regarding the potential increased risk of vascular adverse events (embolization, dissection, stroke, lower extremity ischemia) associated with endoaortic balloon occlusion. We undertook this study to evaluate the vascular risk associated with endoaortic balloon use.MethodsAll patients undergoing minimally invasive, port access, right thoracotomy operations from 1998 to 2012 at our institution were retrospectively analyzed. Patients undergoing aortic occlusion with the Chitwood clamp (n?= 189) were compared with patients undergoing occlusion with the endoaortic balloon (n?= 875).ResultsThere was no statistical difference in the rate of?dissection between patients undergoing aortic occlusion with an endoaortic balloon (1.03%) and those receiving a Chitwood clamp (1.06%). Similarly, there was no difference in the rate of type A dissection between aortic occlusion strategies (endoaortic balloon?= 0.57%, n?= 5, vs Chitwood clamp?= 1.06%, n?= 2, p?= 0.28). No difference in the incidence of stroke was identified between the endoaortic balloon and the Chitwood clamp (2.2% vs 2.1%, p?= 1.0).ConclusionsMinimally invasive cardiac operations using a peripheral cannulation strategy can be safely performed with minimal vascular adverse events incorporating either endoaortic balloon or Chitwood clamp?aortic occlusion. As experience with the endoaortic balloon is gained, the incidence of vascular adverse events can be reduced to?nearly negligible rates.CTSNet classification:35Dr Hargrove discloses financial relationships with Edwards Lifesciences and Sorin.Intracardiac operations are increasingly performed with minimally invasive approaches. Referring cardiologists and patients alike are seeking centers of excellence capable of performing mitral valve, tricuspid valve, atrial septal defect, and intracardiac tumor surgical procedures with nonsternotomy techniques. Several reports from our center and from others have demonstrated excellent technical outcomes that are equivalent to the gold standard sternotomy approaches [